Connection

Michael Lilly to Antigens, CD19

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Antigens, CD19.
Michael Lilly
Connection Strength
0.020
Antigens, CD19
  1. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells. J Clin Invest. 2008 Sep; 118(9):3038-50.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.